NYU

2 NYU scientists named Howard Hughes Medical Institute's Early Career Scientists

Two researchers from NYU School of Medicine have been named Early Career Scientists by the Howard Hughes Medical Institute (HHMI). The honorees, Iannis Aifantis, Ph.D. associate professor of pathology, co-director of the Cancer Stem Cell Program at the NYU Cancer Institute and Jeremy S. Dasen Ph.D...

Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists

Two researchers from NYU School of Medicine have been named Early Career Scientists by the Howard Hughes Medical Institute (HHMI). The honorees, Iannis Aifantis, Ph.D. associate professor of pathology, co-director of the Cancer Stem Cell Program at the NYU Cancer Institute and Jeremy S. Dasen Ph.D...

Norma Smith and Dr. Steven A. Stuchin honored at 2008 Founders Gala for NYU Hospital for Joint Diseases

Proceeds to Support New Ambulatory Musculoskeletal Center NEW YORK, Oct. 27 /PRNewswire/ -- On November 3, leaders of New York's philanthropic, business, government, medical and civic communities will gather together to honor renowned orthopaedic surgeon Dr. Steven A. Stuchin and long-servin...

Stomach bug appears to protect kids from asthma, says NYU study

NEW YORK, July 15, 2008 A long-time microbial inhabitant of the human stomach may protect children from developing asthma, according to a new study among more than 7,000 subjects led by NYU Langone Medical Center researchers. Helicobacter pylori , a bacterium that has co-existed with humans fo...

SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel

Broadcasting live from leading New York City academic medical center, new channel hosted exclusively by doctors, available 24/7 to listeners nationwide Call-in format provides everyday Americans with unprecedented access to world-class phy...

2 NYU faculty elected to National Academy of Sciences

Two New York University professors, Helmut Hofer of NYUs Courant Institute of Mathematical Sciences and Anthony Movshon, director of the universitys Center for Neural Science, have been elected to the National Academy of Sciences, the Washington, D.C.-based organization announced today. Hofer a...

Melanoma lurks in larger skin lesions, NYU researchers find

Skin lesions that are about the size of a pencil eraser are more likely to be melanomas, a deadly form of skin cancer, than smaller moles, according to a new study led by NYU Langone Medical Center researchers. In a new study published in the April issue of Archives of Dermatology, the NYU...

NIH awards NYU College of Dentistry $1.8M to identify risk for severe early childhood caries

New York University College of Dentistrys Dr. Page W. Caufield, a professor of cariology and comprehensive care has received a five-year, $1.83 million grant from the National Institute of Dental and Craniofacial Research (NIDCR), part of NIH, to conduct research to help identify those at risk for...

SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center

World-Class Doctors from one of the Nation's Premier Centers for Medical and Health Care, Research, and Medical Education will Host Live call-in format will give listeners access to first-class doctors NEW YORK, Nov. 12 /PRNewswire-FirstCall/ -- SIRIUS Satellite Radio (Nasdaq: SIRI )...

Clinical trial evaluating brain cancer vaccine is underway at NYU

NEW YORK, October 18, 2007 A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma m...

NYU in Medical Technology

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...hows tangible evidence that New York is positioning itself to become a hub for biopharmaceutical research. The biotech park -- located adjacent to the nyu Langone Medical Center in Manhattan -- will house ImClone's Research Division including approximately 125 ImClone scientists with plans to add scienti...

Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient

... "We need to be more aggressive in treating our patients," Howard S. Weintraub, MD, a cardiologist and Clinical Associate Professor of Medicine at nyu Medical School, said. "This requires individualized testing and early intervention." Weintraub suggested that while gathering a patient's blood ...

New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery

...ggests. The study was conducted by researchers at nyu Langone Medical Center and was published in the la...od and Drug Administration (FDA). The team at nyu Langone sought to determine the effects of deliver...M.D., Director of the Women's Wellness Program at nyu . "These new data on the safety of transdermal HT...

New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation

...lowing for rapid healing, less downtime and profound results. Dr. Sarnoff is a board certified dermatologist and clinical professor of Dermatology at nyu Medical Center. As consumers have become savvier to skin care and laser options, the pendulum is swinging back to more result-oriented treatment...

Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD

...ymptom control for adults with this disorder," said Lenard A. Adler, M.D., lead researcher in this study and director of the Adult ADHD program at the nyu Langone Medical Center, associate professor of psychiatry, neurology and child and adolescent psychiatry at the New York University School of Medicine...

Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain

...ain is helping lead the way to new patient- friendly treatment approaches," said Dr. Michael Gruber, Clinical Professor of Neurology and Neurosurgery, nyu Cancer Institute in New York and Overlook Hospital in New Jersey, two of 11 sites of the clinical trial. "The ongoing results from the prior clinica...

Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies

...t the 2nd Annual Advances in Biomolecular Engineering: Protein Design Symposium, sponsored by the New York Academy of Sciences. Dr. Paul H. Pevsner, nyu School of Medicine (Department of Pharmacology) and principle investigator for the research studies, commented: "PCT is critical to our work. This nov...

ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer

...gin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of Urology at nyu School of Medicine and medical monitor for the trials said, "I have personally reviewed the preliminary data and observed the Sonablate(R) 500 in acti...

Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City

...IC REGIONAL MEETING (MARM 2008 - New York, NY). Dr. Pevsner gave an oral presentation on Tuesday May 20th. In addition, he and his colleagues from the nyu School of Medicine and the Brooklyn Hospital Center also gave four poster presentations at this meeting. Dr. Pevsner's talk centered on the importance...

Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)

...he molecular events that lead to the development of this highly aggressive disease. Using Rosetta Genomics' unique microRNA platform, Dr. Harvey Pass, nyu School of Medicine, examines whether there are distinct mir profiles between MM and normal mesothelium, and whether mirs are associated with demograph...

NYU in Medical Dictionary

Emergency Medicine

...ognized by ACEP as "Heroes of Emergency Medicine " ... The Emergency Medicine Residency is an integrated program, supported by area ... The nyu Department of Emergency Medicine is internationally renowned for its ... Our residency training program in emergency medicine is one of the la...

Bile

... gallbladder ... consisting of salts and bile salts, proteins, cholesterol, hormones, and enzymes. ... Bile , Duct, and Gallbladder Surgery at nyu School of Medicine Department of Laparsocpic Abdominal Surgery ... Stones are in my Bile Duct? Benefits and Risks ... ... or stoppage of bile ...

NYU in Biological News

$29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation

New York, NY July 14, 2009 NYU and NYU School of Medicine received a $29.4 million, five-year Clinical and Translational Science Award from the National Institutes of Health (NIH) to establish a University-wide Clinical & Translational Science Institute (CTSI) in partnership with the New York Ci...

From stem cells to new organs: Stanford and NYU scientists cross threshold in regenerative medicine

By now, most people have read stories about how to "grow your own organs" using stem cells is just a breakthrough away. Despite the hype, this breakthrough has been elusive. A new report published in the March 2009 issue of The FASEB Journal ( http://www.fasebj.org ) brings bioengineered organs ...

A new cellular pathway linked to cancer is identified by NYU researchers

NEW YORK, July 24, 2008 In the life of a cell, the response to DNA damage determines whether the cell is fated to pause and repair itself, commit suicide, or grow uncontrollably, a route leading to cancer. In a new study, published in the July 25th issue of Cell , scientists at NYU Langone Medic...

Hybridization partially restores vision in cavefish, NYU study finds

Hybridizing blind cave fish from different cave populations can partially restore the vision of their offspring, biologists at New York University have found. The study suggests that genetic engineering can override, at least in part, half a million years of evolutionary change in one generation. ...

NYU Langone Medical Center awarded NIH grants totaling $1,560,000

... New York, NY, June 24, 2009 Two nyu Langone Medical Center researchers have received $1,560,000 in grant suppor...om the National Institutes of Health (NIH). The studies being conducted at nyu Langone Medical Center are two of several projects being conducted through ...

Genetic switch potential key to new class of antibiotics

...s much more than a passive middleman, and instead exerts decisive control over expression. Researchers in the Breaker lab at Yale and Nudler lab at nyu reported in 2002 that regulatory mechanisms arising from riboswitches regulate gene expression at the level of the mRNA by changing shape in ways that...

NYU College of Dentistry awarded $1.9 million NIH grant for HIV research

...discovered the mechanism in an earlier study he conducted with the assistance of a one-year pilot grant from CFAR, The Center for AIDS Research at the nyu School of Medicine. HIV normally inserts its DNA into the DNA of the cells it infects in a process called integration that is inefficient and pron...

New potential therapeutic target discovered for genetic disorder -- Barth syndrome

... Researchers at nyu Langone Medical Center may have discovered a new t...e study and assistant professor of cell biology at nyu Langone Medical Center. BTHS syndrome is an X-...f organic acids in urine. In a previous study, nyu researchers documented the characteristics of a ta...

NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis

...tant to therapy, and deadly. Now, scientists from nyu Langone Medical Center have identified the possibl...istant professor in the Department of Pathology at nyu School of Medicine, and the lead author of the study. Dr. Hernando is also a member of the nyu Cancer Institute at...

Consumers desire more genetic testing, but not designer babies

... A new study by researchers at nyu Langone Medical Center found a high desire for add...away, MS CGC, a certified genetic counselor at the nyu Cancer Institute. The article entitled, "Consumers...arry Ostrer, Director of Human Genetics Program at nyu Langone Medical Center. "Our study gauged the cons...

More>>

NYU in Biological Technology

NorthPoint Domain and NYU Vascular Associates Partner to Develop New Generation of Care Delivery Informatics Instruments

BOSTON, May 5 /PRNewswire/ -- NorthPoint Domain, an IC Sciences company, announced today a partnership with New York University Vascular Associates at NYU Langone Medical Center to develop a comprehensive suite of Internet informatics instruments for advanced specialty care delivery. Based on ...

NYU physicists find way to explore microscopic systems through holographic video

...ich is reported in Optics Express , has potential to improve medical diagnostics and drug discovery. The technique, developed in the laboratory of nyu Physics Professor David Grier, is comprised of two components: making and recording the images of microscopic systems and then analyzing these images....

Cynvec to Present at The 2009 New York Venture Summit

... the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the nyu School of Medicine, Cynvec is developing its lead product, CYN 101, to be used as a single agent or in combination with cytotoxics, monoclonal antibod...

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

...ates and Canada, with additional sites in Europe and involves 667 patients under the supervision of lead investigator, Herbert Lepor, MD, Professor at nyu School of Medicine, New York. Patients enter a 4-week run-in no-treatment observation period to confirm severity and stability of voiding symptoms bas...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

...ates and Canada, with additional sites in Europe and involves 667 patients under the supervision of lead investigator, Herbert Lepor, MD, Professor at nyu School of Medicine, New York. Patients enter a 4-week run-in no-treatment observation period to confirm severity and stability of voiding symptoms bas...

Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry

... the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the nyu School of Medicine, Cynvec is developing its lead product, CYN 101, to be used as a single agent or in combination with cytotoxics, monoclonal antibod...

Four Major Universities Join Nation's Leading Postgrad Bio Jobs Board

...ersities have joined Bio Career Center, the nation's leading online jobs board and careers site for life science professionals. UCLA , Brown , nyu and Georgetown are now members of the jobs board, joining 15 other major universities. The jobs board, www.biocareercenter.com , is only for ...

Cynvec to Present at New York Biotechnology Association 18th Annual Meeting

... the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the nyu School of Medicine, Cynvec is developing its lead product, CYN 101, to be used as a single agent or in combination with cytotoxics, monoclonal antibod...

Cynvec to Present at the BIO National Venture Conference

... the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the nyu School of Medicine, Cynvec is developing its lead product, CYN 101, to be used as a single agent or in combination with cytotoxics, monoclonal antibod...

Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference

...ets overexpressed laminin receptors on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the nyu School of Medicine, Cynvec is developing therapies that may be used as a single agent or in combination with cytotoxics, monoclonal antibodies, chemot...